MORNINGSIDE PHARMACEUTICALS LIMITED
Get an alert when MORNINGSIDE PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£100k
-92.6% lowest in 3 filed years
Net assets
£18m
-52.8% lowest in 3 filed years
Employees
47
-36.5% lowest in 3 filed years
Profit before tax
£14m
-22% lowest in 3 filed years
Watch the reel
Our short-form breakdown of MORNINGSIDE PHARMACEUTICALS LIMITED's latest filing
Fewer sales, fewer staff, less profit... but the dividend at Morningside Pharmaceuticals multiplied by five. A £33m payout that more than halved the company's net assets. 💊💷
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £79,429,729 | £84,013,000 | £75,304,000 | -10.4% | |
| Operating profit | £14,435,651 | £17,273,000 | £13,716,000 | -20.6% | |
| Profit before tax | £14,731,195 | £17,830,000 | £13,900,000 | -22% | |
| Net profit | £14,257,743 | £16,004,000 | £13,357,000 | -16.5% | |
| Cash | £5,700,590 | £1,357,000 | £100,000 | -92.6% | |
| Total assets less current liabilities | £27,972,743 | £37,466,000 | £17,613,000 | -53% | |
| Net assets | £27,729,178 | £37,233,000 | £17,562,000 | -52.8% | |
| Equity | £27,729,178 | £37,233,000 | £17,562,000 | -52.8% | |
| Average employees | 93 | 74 | 47 | -36.5% | |
| Wages | £3,075,907 | £2,953,000 | £1,953,000 | -33.9% | |
| Directors' remuneration | £527,629 | £499,000 | £641,000 | +28.5% | |
| Directors' pension contributions | £36,084 | £106,000 | £74,000 | -30.2% | |
| Highest paid director | £189,634 | £237,000 | £203,000 | -14.3% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 18.2% | 20.6% | 18.2% | |
| Net margin | 18.0% | 19.0% | 17.7% | |
| Return on capital employed | 51.6% | 46.1% | 77.9% | |
| Gearing (liabilities / total assets) | 43.1% | 26.5% | 56.7% | |
| Current ratio | 2.13x | 3.50x | 1.75x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- TC Group
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The VPAS (rebate/levy on branded medicines) ended in 2023 and the new Voluntary Scheme (VPAG) will be in place for period of 5 years. The new scheme gives clarity for this period and as expected had a neutral impact to the group once it was fully embedded on new methods from Q2 2024 (Q1 being a transitionary period).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HP SECRETARIAL SERVICES LIMITED | Corporate Secretary | 2023-02-09 | — | — |
| BUCKLEY, Gary David | Director | 2023-07-06 | Feb 1986 | British |
| CONDON, Richard Michael | Director | 2022-09-30 | Aug 1976 | British |
| MAY, Jonathan Charles | Director | 2023-07-06 | Apr 1970 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GADHIA, Tarlaben Kishan | Secretary | 1991-12-18 | 2002-12-31 |
| KOTECHA, Monisha Nikesh | Secretary | 2003-01-01 | 2022-09-30 |
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 1991-12-18 | 1991-12-18 |
| BRADY, Timothy James | Director | 2021-12-01 | 2025-10-31 |
| FUNG, Clifford Roy | Director | 2021-12-01 | 2025-10-31 |
| GADHIA, Danesh Vinodkumar | Director | 1991-12-18 | 2006-01-19 |
| GADHIA, Tarlaben Kishan | Director | 1991-12-18 | 2002-12-31 |
| HUANG, Yanyan | Director | 2021-12-01 | 2023-05-26 |
| KOTECHA, Monisha Nikesh | Director | 2003-01-01 | 2022-09-30 |
| KOTECHA, Nikesh Rasiklal, Dr | Director | 1996-06-01 | 2022-09-30 |
| COMPANY DIRECTORS LIMITED | Corporate Nominee Director | 1991-12-18 | 1991-12-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Randalsun Capital Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-05-21 | Ceased 2022-09-30 |
| Remedi Medical Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2021-05-21 |
Filing timeline
Last 20 of 133 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-01-17 RESOLUTIONS Resolution
- 2023-01-17 MA Memorandum articles
- 2023-01-06 CC02 Notice removal restriction on company articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-29 | AA | accounts | Accounts with accounts type full | |
| 2026-03-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-31 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-31 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-04 | AA | accounts | Accounts with accounts type full | |
| 2025-03-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-25 | AA | accounts | Accounts with accounts type full | |
| 2024-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-21 | AA | accounts | Accounts with accounts type full | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-06-07 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-02-13 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-02-06 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2023-02-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-01-17 | RESOLUTIONS | resolution | Resolution | |
| 2023-01-17 | MA | incorporation | Memorandum articles | |
| 2023-01-13 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-01-06 | CC02 | change-of-constitution | Notice removal restriction on company articles |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.